Trulicity (dulaglutide, diabetes label)
Weekly GLP-1 for type 2 diabetes. Lilly publishes no cash price for it — only a copay card for the commercially insured.
- Medication
- brand
- Form
- injection
Lilly publishes no self-pay price. Its savings card offers 'as little as $25' for up to a 3-month prescription, capped at $1,950 a year and restricted to 13 fills through 31 December 2026 — and only for people commercially insured with coverage for Trulicity.
How much does Trulicity (dulaglutide, diabetes label) cost a month?
halfrx records no verified price for Trulicity (dulaglutide, diabetes label): nothing it publishes states an all-in monthly figure, so this medication carries no price here rather than a guess. What it costs once titrated is not published, which is a fact about the seller rather than a gap in the data. Weekly GLP-1 for type 2 diabetes. Lilly publishes no cash price for it — only a copay card for the commercially insured. No FTC action, state action, BBB F grade or FDA warning letter is recorded against it. It scores 3.6 out of 10 on a published formula that is arithmetic over these stored fields, not an editor's opinion. Lilly publishes no self-pay price. The medication is the branded, FDA-approved product rather than a compounded copy. The page rests on 1 cited source, at least one of them a manufacturer, regulator or journal. Molecule: dulaglutide.
No clinician has reviewed this page. Every clinical statement on it is drawn from the FDA label or the trial cited beside it, and every price carries the date it was verified — but that is sourcing, not medical review, and the two are not the same thing. What we do and do not check · Who checked the price
Pros
Cons
- −Lilly publishes no cash price at all, so nobody paying without insurance can find out what it costs before the counter.[1]
- −The savings card excludes anyone on Medicare, Medicaid, TRICARE, VA or any state programme, and caps Lilly's own contribution at $150 a month.[1]
- −Weight loss is off-label and smaller than the newer agents achieve; the label presents no weight-loss percentage.[1]
How this score is built
- 0.0/3.5Evidence — no pivotal trial for this product
- 3.0/3Approval — FDA approved for type 2 diabetes and cardiovascular risk reduction. Weight loss is off-label use.
- 0.0/2.5Cost — no verified price
- 0.6/1Caveats — −0.4 for off_label_for_weight
Clinical evidence
FDA approved for type 2 diabetes and cardiovascular risk reduction. Weight loss is off-label use.
AWARD trials in type 2 diabetes. Weight change was a secondary endpoint and is smaller than in the obesity trials of the newer agents; halfrx quotes no percentage because the label does not present one as a weight-loss result.
What Trulicity costs without insurance, and every route to the same drug →
Sources
- [1] Trulicity Savings Card terms, Eli Lillyprimary
Information only, not medical advice. Prices and terms change; the date above is when we last verified this one.